Literature DB >> 23386649

Common genetic variants in peroxisome proliferator-activated receptor-γ (PPARG) and type 2 diabetes risk among Women's Health Initiative postmenopausal women.

Kei Hang K Chan1, Tianhua Niu, Yunsheng Ma, Nai-chieh Y You, Yiqing Song, Eric M Sobel, Yi-Hsiang Hsu, Raji Balasubramanian, Yongxia Qiao, Lesley Tinker, Simin Liu.   

Abstract

CONTEXT: Peroxisome proliferator-activated receptor-γ (PPARG) plays a pivotal role in adipogenesis and glucose homeostasis.
OBJECTIVE: We investigated whether PPARG gene variants were associated with type 2 diabetes (T2D) risk in the multiethnic Women's Health Initiative (WHI). RESEARCH DESIGN AND METHODS: We assessed PPARG single-nucleotide polymorphisms (SNPs) in a case-control study nested in the prospective WHI observational study (WHI-OS) (1543 T2D cases and 2170 matched controls). After identifying 24 tagSNPs, we used multivariable logistic regression models and haplotype-based analyses to estimate these tagSNP-T2D associations. Single-SNP analyses were also conducted in another study of 5642 African American and Hispanic American women in the WHI SNP Health Association Resource (WHI-SHARe).
RESULTS: We found a borderline significant association between the Pro12Ala (rs1801282) variant and T2D risk in WHI-OS [odds ratio (OR) 0.51, 95% confidence interval (CI) 0.31-0.83, P = .01, combined group, additive model; P = .04, Hispanic American] and WHI-SHARe (OR 0.25, 95% CI 0.08-0.77, P = .02, Hispanic American) participants. In promoter region, rs6809631, rs9817428, rs10510411, rs12629293, and rs12636454 were also associated with T2D risk (range ORs 0.68-0.78, 95% CIs 0.52-0.91 to 0.60-1.00, P ≤ .05) in WHI-OS, in which rs9817428 was replicated in then WHI-SHARe Hispanic American group (P = .04).
CONCLUSIONS: The association between PPARG Pro12Ala SNP and increased T2D susceptibility was confirmed, with Pro12 as risk allele. Additional significant loci included 5 PPARG promoter variants.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23386649      PMCID: PMC3590470          DOI: 10.1210/jc.2012-3644

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

Review 1.  Peroxisome proliferator-activated receptor translational research and clinical experience.

Authors:  Wayman Wendell Cheatham
Journal:  Am J Clin Nutr       Date:  2009-11-18       Impact factor: 7.045

2.  Evidence for gene-nutrient interaction at the PPARgamma locus.

Authors:  J Luan; P O Browne; A H Harding; D J Halsall; S O'Rahilly; V K Chatterjee; N J Wareham
Journal:  Diabetes       Date:  2001-03       Impact factor: 9.461

3.  Association study of genetic variants in eight genes/loci with type 2 diabetes in a Han Chinese population.

Authors:  Ying Lin; Pengqiu Li; Li Cai; Ben Zhang; Xin Tang; Xuejun Zhang; Ying Li; Yang Xian; Yang Yang; Li Wang; Fang Lu; Xiaoqi Liu; Shaoqin Rao; Ming Chen; Shi Ma; Yi Shi; Mingjing Bao; Jichuan Wu; Yan Yang; Jiyun Yang; Zhenglin Yang
Journal:  BMC Med Genet       Date:  2010-06-15       Impact factor: 2.103

4.  Investigation of type 2 diabetes risk alleles support CDKN2A/B, CDKAL1, and TCF7L2 as susceptibility genes in a Han Chinese cohort.

Authors:  Jie Wen; Tina Rönn; Anders Olsson; Zhen Yang; Bin Lu; Yieping Du; Leif Groop; Charlotte Ling; Renming Hu
Journal:  PLoS One       Date:  2010-02-10       Impact factor: 3.240

5.  Curbing type I and type II errors.

Authors:  Kenneth J Rothman
Journal:  Eur J Epidemiol       Date:  2010-03-16       Impact factor: 8.082

Review 6.  The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis.

Authors:  Hebe N Gouda; Gurdeep S Sagoo; Anne-Helen Harding; Jan Yates; Manjinder S Sandhu; Julian P T Higgins
Journal:  Am J Epidemiol       Date:  2010-02-23       Impact factor: 4.897

Review 7.  The many faces of PPARgamma: anti-inflammatory by any means?

Authors:  Attila Szanto; Laszlo Nagy
Journal:  Immunobiology       Date:  2008-09-02       Impact factor: 3.144

Review 8.  From bench to bedside: novel mechanisms and therapeutic advances through the development of selective peroxisome proliferator-activated receptor gamma modulators.

Authors:  George L Blackburn
Journal:  Am J Clin Nutr       Date:  2009-11-18       Impact factor: 7.045

Review 9.  PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?

Authors:  W Ahmed; O Ziouzenkova; J Brown; P Devchand; S Francis; M Kadakia; T Kanda; G Orasanu; M Sharlach; F Zandbergen; J Plutzky
Journal:  J Intern Med       Date:  2007-08       Impact factor: 8.989

10.  Clinical risk factors, DNA variants, and the development of type 2 diabetes.

Authors:  Valeriya Lyssenko; Anna Jonsson; Peter Almgren; Nicoló Pulizzi; Bo Isomaa; Tiinamaija Tuomi; Göran Berglund; David Altshuler; Peter Nilsson; Leif Groop
Journal:  N Engl J Med       Date:  2008-11-20       Impact factor: 91.245

View more
  7 in total

1.  Association of PPARγ gene polymorphisms with osteoarthritis in a southeast Chinese population.

Authors:  Ding Zheru; Fu Peiliang; Wu Yuli; Wu Haishan; Qian Qirong; Li Xiaohua; Zhao Hui; Wang Bo; Fu Qiwei
Journal:  J Genet       Date:  2014-12       Impact factor: 1.166

Review 2.  Is the Mouse a Good Model of Human PPARγ-Related Metabolic Diseases?

Authors:  Attila Pap; Ixchelt Cuaranta-Monroy; Matthew Peloquin; Laszlo Nagy
Journal:  Int J Mol Sci       Date:  2016-07-30       Impact factor: 5.923

3.  Single-Nucleotide Polymorphism of PPARγ, a Protein at the Crossroads of Physiological and Pathological Processes.

Authors:  Maria Petrosino; Laura Lori; Alessandra Pasquo; Clorinda Lori; Valerio Consalvi; Velia Minicozzi; Silvia Morante; Antonio Laghezza; Alessandra Giorgi; Davide Capelli; Roberta Chiaraluce
Journal:  Int J Mol Sci       Date:  2017-02-10       Impact factor: 5.923

4.  The Gene-Diet Associations in Postmenopausal Women with Newly Diagnosed Dyslipidemia.

Authors:  B Grygiel-Górniak; E Kaczmarek; M Mosor; J Przysławski; J Nowak
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

5.  Association between peroxisome proliferator-activated receptor-alpha, -delta and -gamma gene (PPARA, PPARD, PPARG) polymorphisms and overweight parameters in physically active men.

Authors:  Ewelina Maculewicz; Andrzej Mastalerz; Agnieszka Maciejewska-Skrendo; Paweł Cięszczyk; Anna Cywińska; Anna Borecka; Aleksandra Garbacz; Ewa Szarska; Łukasz Dziuda; Katarzyna Lorenz; Roman Łakomy; Tomasz Lepionka; Anna Anyżewska; Agnieszka Białek; Jerzy Bertrandt
Journal:  Biol Sport       Date:  2021-12-28       Impact factor: 4.606

6.  Rare mutations of peroxisome proliferator-activated receptor gamma: frequencies and relationship with insulin resistance and diabetes risk in the mixed ancestry population from South Africa.

Authors:  Z Vergotine; A P Kengne; R T Erasmus; Y Y Yako; T E Matsha
Journal:  Int J Endocrinol       Date:  2014-08-14       Impact factor: 3.257

Review 7.  Type 2 Diabetes-Associated Genetic Polymorphisms as Potential Disease Predictors.

Authors:  Beska Z Witka; Dede J Oktaviani; Marcellino Marcellino; Melisa I Barliana; Rizky Abdulah
Journal:  Diabetes Metab Syndr Obes       Date:  2019-12-18       Impact factor: 3.168

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.